A single in vivo administration of bombesin antagonist RC-3095 reduces the levels and mRNA expression of epidermal growth factor receptors in MXT mouse mammary cancers

Ítems similars

• Reduction in receptors for bombesin and epidermal growth factor in xenografts of human small-cell lung cancer after treatment with bombesin antagonist RC-3095
  per: Halmos, Gabor, et al.
  Publicat: (1997)
• Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice.
  per: Pinski, J., et al.
  Publicat: (1994)
• Bombesin antagonists inhibit proangiogenic factors in human experimental breast cancers
  per: Bajo, A M, et al.
  Publicat: (2004)
• Bombesin antagonists inhibit growth of MDA-MB-435 estrogen-independent breast cancers and decrease the expression of the ErbB-2/HER-2 oncoprotein and c-jun and c-fos oncogenes
  per: Bajo, Ana M., et al.
  Publicat: (2002)
• Design, synthesis, and in vitro evaluation of cytotoxic analogs of bombesin-like peptides containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin
  per: Nagy, Attila, et al.
  Publicat: (1997)